These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20947151)

  • 1. Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.
    Long KC; Levinson KL; Diaz JP; Gardner GJ; Chi DS; Barakat RR; Leitao MM
    Gynecol Oncol; 2011 Jan; 120(1):33-7. PubMed ID: 20947151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RE: "Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers".
    Fagotti A; Vizzielli G; Scambia G
    Gynecol Oncol; 2011 Jul; 122(1):201; author reply 201-2. PubMed ID: 21402402
    [No Abstract]   [Full Text] [Related]  

  • 3. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
    Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
    Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Shih KK; Chi DS; Barakat RR; Leitao MM
    Gynecol Oncol; 2010 Mar; 116(3):364-9. PubMed ID: 19897231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers.
    Krill LS; Ueda SM; Gerardi M; Bristow RE
    Gynecol Oncol; 2011 Feb; 120(2):220-3. PubMed ID: 21145096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study.
    Spirtos NM; Eisekop SM; Boike G; Schlaerth JB; Cappellari JO
    Am J Obstet Gynecol; 2005 Nov; 193(5):1645-9. PubMed ID: 16260204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
    Usami T; Kato K; Taniguchi T; Abe A; Nomura H; Yamamoto A; Matoda M; Okamoto S; Kondo E; Omatsu K; Kawamata Y; Takeshima N
    Int J Gynecol Cancer; 2014 Jul; 24(6):991-6. PubMed ID: 24905612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is minimal invasive surgery for primary and secondary debulking of ovarian/peritoneal/fallopian tube cancer going too far?
    Gorostidi M
    Int J Gynecol Cancer; 2014 Sep; 24(7):1138-9. PubMed ID: 25054450
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.
    Leitao MM; Natenzon A; Abu-Rustum NR; Chi DS; Sonoda Y; Levine DA; Gardner GJ; Barakat RR
    Gynecol Oncol; 2009 Nov; 115(2):204-8. PubMed ID: 19740532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
    Chi DS; Franklin CC; Levine DA; Akselrod F; Sabbatini P; Jarnagin WR; DeMatteo R; Poynor EA; Abu-Rustum NR; Barakat RR
    Gynecol Oncol; 2004 Sep; 94(3):650-4. PubMed ID: 15350354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced cytoreductive surgery: American perspective.
    Zivanovic O; Aldini A; Carlson JW; Chi DS
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S3-9. PubMed ID: 19573703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of video laparoscopic surgical debulking of recurrent ovarian, fallopian tube, and primary peritoneal cancers.
    Nezhat FR; Denoble SM; Cho JE; Brown DN; Soto E; Chuang L; Gretz H; Saharia P
    JSLS; 2012; 16(4):511-8. PubMed ID: 23484556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience.
    Peiretti M; Zanagnolo V; Aletti GD; Bocciolone L; Colombo N; Landoni F; Minig L; Biffi R; Radice D; Maggioni A
    Gynecol Oncol; 2010 Nov; 119(2):259-64. PubMed ID: 20800269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.
    Shih KK; Chi DS; Barakat RR; Leitao MM
    Gynecol Oncol; 2010 May; 117(2):330-5. PubMed ID: 20189234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer.
    Bashir S; Gerardi MA; Giuntoli RL; Montes TP; Bristow RE
    Gynecol Oncol; 2010 Nov; 119(2):255-8. PubMed ID: 20739051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome.
    Nezhat FR; Ezzati M; Chuang L; Shamshirsaz AA; Rahaman J; Gretz H
    Am J Obstet Gynecol; 2009 Jan; 200(1):83.e1-6. PubMed ID: 19019337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
    Andikyan V; Kim A; Gretz HF; Zakashansky K; Prasad-Hayes M; Beddoe AM; Dottino P; Mandeli J; Chuang L
    Am J Clin Oncol; 2018 Oct; 41(10):938-942. PubMed ID: 29624506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.